TeOra.png

We scale it down.  

Before we scale it up.

 
Submission 2 (1) (1).png

Here is where it gets interesting. 

 

We then miniaturise the key creation & selection processes onto our proprietary microfluidics platform.

 

This means replicating full-scale lab processes more efficiently on a platform that is no more than the length of your pinkie. 

OPTIMISE

Background.png
Background_edited.png

1

2

3

2 inches

INSERT the top designs into biofactories (microorganisms)

1

bacteria_edited_edited.png
bacteria_edited_edited.png
bacteria_edited_edited.png

SELECT the highest performing microorganism that optimally expresses target compound or peptide

2

bacteria_edited_edited.png
bacteria_edited_edited.png
edited gif.gif
1GQ5_edited.png
1GQ5_edited_edited.png
1GQ5_edited.png

PROTECT & DELIVER

And our final step sets us apart.

 

We apply our proprietory encapsulation technology to the purified output. This allows the product to be optimised for effective delivery and bioavailability across a wide range of applications.

In other words, we wrap things up perfectly, for maximum effect.

3

Encapsulation of droplets on our miniaturised platform (600x magnification)

imageedit_2_7389409100.gif
Submission 2 (1) (1).png

DESIGN

We start from designing the ideal compound or peptide using bioinformatics

We custom design single and complex multi-gene blueprints.

1GQ5_edited.png
 
 
Submission 2 (1) (1).png

Only the single BEST microorganism is scaled up.

 

This microorganism propagates and consumes sustainable raw materials (sugar, water, nutrients) in a bioreactor to produce larger volumes of the target compound or peptide.

SCALE UP

brewery.png
 
Submission 2 (1) (1).png

EFFICIENT & SUSTAINABLE

Since we miniaturise processes onto our proprietory microfluidics platform, we are more efficient than other incumbent technologies.

Up to 100x times more.
 
Screenshot 2021-09-21 at 6.01_edited.jpg

LOWER COST

Our miniaturised process replaces large equipment and cuts reagent costs by 90%

Our miniaturised process replaces large equipment and cuts reagent costs by 90%

Our miniaturised process replaces large equipment and cuts reagent costs by 90%

Our miniaturised process replaces large equipment and cuts reagent costs by 90%

MORE SUSTAINABLE

Each reaction is carried out as a tiny droplet which means 1,000,000x less plastic, sample and reagent wastage 

Our miniaturised process replaces large equipment and cuts reagent costs by 90%

ENHANCED SPEED

Parallel processing reduces the time to identify successful biofactories by 10x, from months to a week